Auro-Losartan Product Recall (2021-05-27)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Auro-Losartan 25 mg Tablet
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| WB5019001-A, WB5019001-B | - Recalling Firm
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
- Marketing Authorization Holder
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
| B. Auro-Losartan 50 mg Tablet | DIN 02403331 | Tablet | Losartan Potassium 50 mg |
| WB1019001-A, WB1019001-B | - Recalling Firm
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
- Marketing Authorization Holder
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
| C. Auro-Losartan 100 mg Tablet | DIN 02403358 | Tablet | Losartan Potassium 100 mg |
| WB2519001-A | - Recalling Firm
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
- Marketing Authorization Holder
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
| A. Auro-Losartan 25 mg Tablet | DIN 02403323 | Tablet | Losartan Potassium 25 mg |
-
Auro-Losartan 25 mg Tablet
-
Auro-Losartan 50 mg Tablet
-
Auro-Losartan 100 mg Tablet
Presence of impurity 5-(4-(azidomethyl)-[1,1-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration limit in affected lots.